Rafael Holdings, Inc. (NYSE:RFL) Sees Large Increase in Short Interest

Rafael Holdings, Inc. (NYSE:RFL) was the target of a large increase in short interest in the month of August. As of August 31st, there was short interest totaling 789,900 shares, an increase of 97.7% from the August 15th total of 399,613 shares. Approximately 2.3% of the shares of the stock are short sold. Based on an average trading volume of 124,437 shares, the short-interest ratio is presently 6.3 days.

Rafael Price Performance

Shares of NYSE RFL traded down $0.03 on Wednesday, hitting $2.11. The company’s stock had a trading volume of 66,318 shares, compared to its average volume of 126,388. Rafael has a 12-month low of $1.12 and a 12-month high of $3.96. The company has a market capitalization of $109.72 million, a price-to-earnings ratio of -3.10 and a beta of 0.40. The stock has a 50 day moving average of $2.20 and a 200-day moving average of $1.83.

Institutional Investors Weigh In On Rafael

An institutional investor recently bought a new position in Rafael stock. Kahn Brothers Group Inc. purchased a new position in shares of Rafael Holdings, Inc. (NYSE:RFL) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 58,557 shares of the company’s stock, valued at approximately $73,196,000. Rafael makes up 0.1% of Kahn Brothers Group Inc.’s holdings, making the stock its 13th largest holding. Kahn Brothers Group Inc. owned 0.11% of Rafael at the end of the most recent reporting period. 11.30% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on RFL shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rafael in a report on Tuesday, August 25th. Wall Street Zen raised Rafael to a “hold” rating in a report on Saturday, July 25th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

About Rafael

Rafael Holdings, Inc is a diversified holding company focused primarily on commercial real estate and life sciences. The company’s real estate activities include ownership and management of commercial properties, with a focus on properties in the New York metropolitan area and other strategic locations.

Through its life sciences investments and subsidiaries, Rafael Holdings has supported the development of oncology treatments and other pharmaceutical technologies. Its best-known biotechnology subsidiary, Rafael Pharmaceuticals, developed investigational cancer therapies, including devimistat, a treatment designed to target cancer-cell metabolism.